Skip to content

COSCIENS Biopharma Inc.

CSCIF

CIK 0001113423 · Perfumes, Cosmetics & Other Toilet Preparations · OTC

  • Aeterna Zentaris Inc. (until 2024-08-07)
  • AETERNA LABORATORIES INC (until 2004-05-25)
← back to feed
Revenue (TTM)
$7.6M
−21.8% YoY FY Dec 2025
Net Income (TTM)
−$13.93M
+32.3% YoY FY Dec 2025
EPS Diluted (TTM)
−$4.43
+44.9% YoY FY Dec 2025
Gross Margin
39.4%
FY Dec 2025
Operating Margin
-191.8%
FY Dec 2025
Net Margin
-183.2%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$7.31M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
3.18M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings